1
|
Žnidarič M, Kozinc Z, Škrinjar D. Potential of molecular biophysical stimulation therapy in chronic musculoskeletal disorders: a narrative review. Eur J Transl Myol 2023; 33:11894. [PMID: 37946516 PMCID: PMC10811630 DOI: 10.4081/ejtm.2023.11894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2023] [Accepted: 10/29/2023] [Indexed: 11/12/2023] Open
Abstract
Current treatment of chronic musculoskeletal diseases does not give sufficient results despite the implementation of novel drugs and techniques in orthopaedics and physical therapy. For instance, osteoporosis treatment is currently mainly limited to drug application, while the goal of osteoarthritis treatment is to mitigate pain symptoms through physical therapy. The main therapeutic principle in the management of osteoporosis is not only to increase bone mass, but also to improve bone and the cartilage quality, which depends on the biomechanical balance. Therefore, there is a strong demand for advanced technologies that would safely and non-invasively accelerate cartilage regeneration and improve bone density. Ten years ago, a new state-of-the-art technology - "Molecular biophysical stimulation therapy (MBST)", specifically nuclear magnetic resonance therapy, emerged on the medical technology market and until now, it has shown successful results in the conservative treatment of musculoskeletal disorders, including back pain. The aim of this review is to provide an integrated, synthesized overview of the current evidence of efficacy of MBST for managing chronic musculoskeletal disorders.
Collapse
Affiliation(s)
| | - Ziga Kozinc
- Faculty of Health Science, University of Primorska, Izola, Slovenia; Andrej Marušič Institute, University of Primorska, Koper.
| | | |
Collapse
|
5
|
Abstract
OptoBase is an online platform for molecular optogenetics. At its core is a hand-annotated and ontology-supported database that aims to cover all existing optogenetic switches and publications, which is further complemented with a collection of convenient optogenetics-related web tools. OptoBase is meant both for expert optogeneticists to easily keep track of the field, as well as for all researchers who find optogenetics inviting as a powerful tool to address their biological questions of interest. It is available at https://www.optobase.org . This work also presents OptoBase-based analysis of the trends in molecular optogenetics.
Collapse
Affiliation(s)
- Katja Kolar
- Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany
- BIOSS − Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany
| | | | - Hendrik Stork
- Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany
| | - Matej Žnidarič
- Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland
| | - Wilfried Weber
- Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany
- BIOSS − Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany
| |
Collapse
|
7
|
Mircsof D, Langouët M, Rio M, Moutton S, Siquier-Pernet K, Bole-Feysot C, Cagnard N, Nitschke P, Gaspar L, Žnidarič M, Alibeu O, Fritz AK, Wolfer DP, Schröter A, Bosshard G, Rudin M, Koester C, Crestani F, Seebeck P, Boddaert N, Prescott K, Hines R, Moss SJ, Fritschy JM, Munnich A, Amiel J, Brown SA, Tyagarajan SK, Colleaux L. Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects. Nat Neurosci 2015; 18:1731-6. [PMID: 26571461 PMCID: PMC5392243 DOI: 10.1038/nn.4169] [Citation(s) in RCA: 61] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Accepted: 10/15/2015] [Indexed: 12/14/2022]
Abstract
The NONO protein has been characterized as an important transcriptional regulator in diverse cellular contexts. Here we show that loss of NONO function is a likely cause of human intellectual disability and that NONO-deficient mice have cognitive and affective deficits. Correspondingly, we find specific defects at inhibitory synapses, where NONO regulates synaptic transcription and gephyrin scaffold structure. Our data identify NONO as a possible neurodevelopmental disease gene and highlight the key role of the DBHS protein family in functional organization of GABAergic synapses.
Collapse
Affiliation(s)
- Dennis Mircsof
- Chronobiology and Sleep Research Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.,Neuromorphology Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Maéva Langouët
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Marlène Rio
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France.,Service de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Sébastien Moutton
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Karine Siquier-Pernet
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Christine Bole-Feysot
- Genomic Platform, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Nicolas Cagnard
- Bioinformatic Platform, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Patrick Nitschke
- Bioinformatic Platform, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Ludmila Gaspar
- Chronobiology and Sleep Research Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Matej Žnidarič
- Chronobiology and Sleep Research Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Olivier Alibeu
- Genomic Platform, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Ann-Kristina Fritz
- Institute of Anatomy, University of Zürich and Institute of Human Movement Sciences and Sport, ETH Zürich, Switzerland
| | - David P Wolfer
- Institute of Anatomy, University of Zürich and Institute of Human Movement Sciences and Sport, ETH Zürich, Switzerland
| | - Aileen Schröter
- Molecular Imaging and Functional Pharmacology Group, University of Zürich, Zürich, Switzerland
| | - Giovanna Bosshard
- Neuromorphology Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Markus Rudin
- Molecular Imaging and Functional Pharmacology Group, University of Zürich, Zürich, Switzerland
| | - Christina Koester
- Neuromorphology Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Florence Crestani
- Neuromorphology Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Petra Seebeck
- Center for Integrative Rodent Physiology, University of Zürich, Zürich, Switzerland
| | - Nathalie Boddaert
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France.,Service de radiologie pédiatrique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Katrina Prescott
- Yorkshire Regional Genetics Service, Leeds Teaching Hospitals National Health Service Trust, Department of Clinical Genetics, Chapel Allerton Hospital, Chapeltown Road, Leeds, UK
| | | | - Rochelle Hines
- Tufts University, Sackler School of Graduate Biomedical Sciences, Boston, Massachusetts, USA
| | - Steven J Moss
- Tufts University, Sackler School of Graduate Biomedical Sciences, Boston, Massachusetts, USA
| | - Jean-Marc Fritschy
- Neuromorphology Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Arnold Munnich
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| | - Jeanne Amiel
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France.,Service de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Steven A Brown
- Chronobiology and Sleep Research Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Shiva K Tyagarajan
- Neuromorphology Group, Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
| | - Laurence Colleaux
- INSERM UMR 1163, Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
| |
Collapse
|